Larimar Therapeutics, Inc.LRMRNASDAQ
Loading
Operating Cash Flow Growth Recovery in ProgressRecovering
Percentile Rank29
Studio
Year-over-Year Change

Year-over-year operating cash flow growth rate

Percentile
P29
Within normal range
vs 3Y Ago
-1.7x
Contraction
Streak
1 yr
Consecutive growthRecovering
PeriodValue
2025-59.98%
2024-111.48%
2023-21.36%
202234.52%
20210.22%
2020-85.91%
201955.91%
2018-17.59%
201715.76%
201612.73%